近年來，心血管介入正向“更小切口、更智能、更個性化”方向邁進。比如生物可降解支架（Implantation of bioresorbable vascular scaffolds），術后幾年可被機體吸收，減少長期異物影響；機器人輔助手術則讓操作更精確。甚至未來遠程手術已不是幻想。全球醫學期刊（Buchanan et al., 2021）評價：“智能介入設備為疑難病例帶來了新希望”。
Doyle, B. J., Rihal, C. S., Gastineau, D. A., Holmes, D. R. Jr. (2008). Bleeding, Blood Transfusion, and Increased Risk of Death After Percutaneous Coronary Intervention: Implications for Contemporary Practice. Journal of the American College of Cardiology, 51(8), 855–862. [link]
Benjamin, E. J., Muntner, P., Alonso, A., et al. (2021). Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association. Circulation, 143(8), e254–e743. [link]
Buchanan, G. L., Chieffo, A., Grey, C., et al. (2021). Innovations in Percutaneous Coronary Intervention: The Role of New Devices and Technologies. European Heart Journal, 42(3), 229-239. [link]
